Novel compounds
CA 2236489 A1 · Owner: Duckworth, David Malcolm · Inventors: Ruben, Steven M.; Duckworth, David Malcolm; Hastings, Gregg A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
HPMBQ91 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing HPMBQ91 polypeptides and polynucleotides in the design of protocols for the treatment of neuronal disorders including pain, CNS related disorders gastrointestinal disorders, cardiovascular disorders metabolic disorders including diabetes and obesity smooth muscle, disorders, inflammatory disorders including asthma cancers including adenomas, leiomyomas liposarcomas, lipomas, melanomas, pulmonary chondroid hamartomas lung cancer, prostate, cancer and breast cancer among others, and diagnostic assays for such conditions.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 6, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 6, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 6, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.